Diagnostic value of cardiac magnetic resonance in myocardial hypertrophy

Lingling WANG,Qiuying YAO,Lianming WU,Jianrong XU,Zi WANG,Meng JIANG,Ben HE
2017-01-01
Abstract:Objective To clarify the existence and etiology of myocardial hypertrophy and the presence of myocardial fibrosis in patients with echocardiographically suspected myocardial hypertrophy using cardiac magnetic resonance (CMR) examination,and to assess the safety of CMR examination.Methods Patients with echocardiographically suspected myocardial hypertrophy (defined as myocardial thickness at any segment > 11 mm at the end of cardiac diastole) were recruited in our hospital between July 2014 and February 2016.CMR examination was performed in order to definitize the existence and the etiology of myocardial hypertrophy.The myocardial fibrosis was detected by the late gadolinium enhancement (LGE).Moreover,CMR safety was assessed.Results Totally 216 patients were enrolled in this study.The agreement rate for etiologic diagnosis over myocardial hypertrophy was 82.4% between CMR and echocardiography (patients with unexplained myocardial hypertrophy were excluded).Hypertrophic cardiomyopathy and hypertensive heart disease were the main causes of hypertrophy.CMR examination found that 53 patients were confirmed as hypertensive heart disease,117 patients with hypertrophic cardiomyopathy,3 patients with myocardial amyloidosis,5 patients with systemic diseases related myocardial hypertrophy,3 patients with unexplained myocardial hypertrophy,18 patients without hypertrophy,and 17 patients with a new diagnosis of other diseases.in addition,unexpected cardiac findings were detected by CMR in 6 patients (2.8%).For the hyperenhancement,myocardial fibrosis was found in 69.7% of the patients.The hyperenhancement rate was 38.9% in the hypertensive heart disease group,which was significantly lower than that in the hypertrophic cardiomyopathy group (82.1%,P<0.05).CMRinduced adverse reactions hardly appeared,except one patient (0.5%) presented nausea and vomiting during contrast administration.Conclusion CMR is a noninvasive and safe strategy,which not only contributes more information in the final diagnosis of myocardial hypertrophy and additional etiologic diagnosis of others diseases,but also deepens the understanding of the tissue characterization.(Shanghai Med J,2017,40:214-218)
What problem does this paper attempt to address?